MaxCyte Inc. IPO Research Information

MaxCyte Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on MaxCyte Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
MaxCyte Inc.	MXCT - NASDAQ	$11.50-$13.50	$13.00	$16.99	13.5 million	7/30/2021
Underwriter(s): Cowen, Stifel, William Blair
Co-Manager(s): BTIG, Stephens
Industry: Health Care
Filing(s): Filed 2021-07-09 Terms Added 2021-07-26

MaxCyte Inc. Quote & Chart - Click for current quote - MXCT

About MaxCyte Inc. (adapted from MaxCyte Inc. prospectus):
They are a leading commercial cell engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MXCT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.